Long-term outcome of left main coronary artery stenting using the provisional stenting technique and the impact of cardiorenal-metabolic syndrome on clinical results

Mankovskyi G.
State Institution «Center of Cardiology and Cardiac Surgery of the Ministry of Health of Ukraine», Kyiv

DOI : https://doi.org/10.57105/2415-7252-2025-3-02

Abstract 

The article presents the results of a prospective study involving 178 patients with coronary artery disease and significant left main coronary artery (LMCA) stenosis. Long-term outcomes after percutaneous coronary intervention (PCI) using the provisional stenting technique were compared with surgical revascularization, in patients with and without cardiorenal-metabolic syndrome (CRMS). It was found that CRMS significantly worsens the prognosis after PCI, while coronary artery bypass grafting neutralizes this negative impact. The findings emphasize the importance of assessing CRMS status when selecting a revascularization strategy in patients with LMCA lesions.

Key wards: coronary artery disease, left main coronary artery, cardiorenal-metabolic syndrome, revascularization, percutaneous coronary intervention, stenting, prognosis, recurrence, treatment strategy

References:

  1. Bhogal S., Zhang C., Aladin A. I., Mintz G. S., Waksman R. Provisional versus dual stenting of left main coronary artery bifurcation lesions: мета-аналіз. Am J Cardiol. 2022;185:10– 17. doi:10.1016j.amjcard.2022.09.012
  2. Arunothayaraj S., Egred M., Banning A. P. та ін. Stepwise provisional vs systematic dual-stent strategies for true left main bifurcation (EBC-MAIN). Circulation. 2025;151(9):612–622. doi:10.1161/CIRCULATIONAHA.124.071153
  3. Paradies V., Chieffo A., Van Mieghem N. Provisional strategy for left main stem bifurcation disease: огляд. JACC Cardiovasc Interv. 2022;15(1). doi:10.1016/j.jcin.2022.12.022
  4. Hildick-Smith D., Egred M., Banning A. та ін. European Bifurcation Club Left Main Stent study: provisional vs dual strategy. Eur Heart J. 2021;42:3829–3839.
  5. When and how to perform the provisional approach for distal LM stenting. EuroIntervention. 2024.
  6. Comparison between provisional and dual systematic stenting for LM bifurcation disease: метааналіз. Sci Direct. 2024. 7. A holistic approach to managing cardio-kidney metabolic syndrome. Front Cardiovasc Med. 2023. doi:10.3389/ fcvm.2025.1583702
  7. Contemporary Left Main Percutaneous Coronary Intervention: state-of-art review. Interventional Cardiology. 2023;18:e20.
  8. Neumann F. J., Sousa-Uva M., Ahlsson A. та ін. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi:10.1093/eurheartj/ ehy394
  9. Chen S. L., Santoso T., Zhang J. J. Clinical outcome of DK-CRUSH-II vs provisional: 5-річний RCT. Circ Cardiovasc Interv. 2017;10(2):e004497. doi:10.1161/CIRCINTER-VENTIONS.116.004497
  10. Ferdinand K. C. Overview of cardiovascular-kidney-metabolic syndrome. Am J Manag Care. 2024;30(suppl 10):S181– S188. doi:10.37765/ajmc.2024.89670
  11. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory from the American Heart Association. Circulation. 2023. doi:10.1161/cir.0000000000001184
  12. A holistic approach to managing CKM syndrome. Front Cardiovasc Med. 2025. doi:10.3389/fcvm.2025.1583702
  13. Combination of cardiovascular, kidney, and metabolic diseases: pathophysiology. Kidney Rep. 2024. doi:10.1016/j. ekir.2024.05.004
  14. Advancing Cardiovascular, Kidney, and Metabolic Medicine: огляд GLP-1 RAs. Springer. 2025. doi:10.1007/ s13300-025-01738-3
PDF (українська)

Published
2025

How to Cite

Mankovskyi G.(2025). Long-term outcome of left main coronary artery stenting using the provisional stenting technique and the impact of cardiorenal-metabolic syndrome on clinical results. Diabetes Obesity Metabolic Syndrome. 3(14), 57-61.